Ophthalmology Times

Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ

LENZ Therapeutics and Lotus Pharmaceutical announced Lotus has submitted a New Drug Application (NDA) to the Ministry of Food ...
Ophthalmology Times

Phase 1 trial confirms safety and tolerability of Huons’ dry eye therapy

HUC1-394 is a peptide-based eye drop for dry eyes, licensed from NOVACELL Technology. According to the company, HUC1-394 ...
Ophthalmology Times

Belite Bio releases topline results from phase 3 DRAGON trial of Tinlarebant for STGD1

Belite Bio has released topline results from the global phase 3 DRAGON trial of Tinlarebant in patients with Stargardt ...
Ophthalmology Times

Kiora Pharmaceuticals receives patent for additional and novel formulations of KIO-100 compounds

The US Patent and Trademark Office has issued a new patent (US Patent No. 12,472,263) on additional and novel formulations of ...
Ophthalmology Times

Prevent Blindness delegates first week of December as 5th annual geographic atrophy week

Prevent Blindness has declared the first week of December as its 5th annual geographic atrophy (GA) week to educate the ...